PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
29-Oct-2024 Dr. Falk Pharma acquires spinout Kynos Therapeutics to develop novel KMO inhibitors for acute pancreatitis Edinburgh Innovations
29-Oct-2024 Medidata and Cogstate Strike Strategic Partnership Transforming Clinical Trials in Neurology with Clinical Outcome Assessment (eCOA) and Clinician Solutions Powered by AI and Advanced Analytics Medidata
29-Oct-2024 Almirall launches the campaign “Me & My Inner Circle” to acknowledge the vital role of friends and family for people living with psoriasis Almirall
29-Oct-2024 Alira Health Releases Global Report on Trends and Competitive Dynamics in the Biosimilar Market Alira Health
29-Oct-2024 TREMFYA® (Guselkumab) is the first IL-23 inhibitor to demonstrate robust results with a fully subcutaneous regimen in both induction and maintenance in Crohn’s disease JOHNSON & JOHNSON
28-Oct-2024 Almirall´s 2024 Immunoskin conference hosts leading experts in inflammatory skin conditions to advance science and treatment options Almirall
28-Oct-2024 UPM Biomedicals launches FibGel™ the world’s first injectable nanocellulose hydrogel for medical devices UPM Biomedicals
28-Oct-2024 Fasenra approved in the EU for eosinophilic granulomatosis with polyangiitis AstraZeneca
28-Oct-2024 Innovative Trials named a top UK women-powered company in clinical research Innovative Trials
28-Oct-2024 Ottimo Pharma Emerges from Stealth with Backing from Medicxi and Management Team Led by David Epstein to Accelerate Development of a Novel PD1/VEGFR2 Bi-Functional Antibody Planned to Enter the Clinic in 2025 Ottimo Pharma
28-Oct-2024 ProQR Announces Closing of Underwritten Public Offering and Concurrent Private Placement ProQR
28-Oct-2024 Sanofi Q3: 15.7% sales growth boosted by earlier-than-anticipated vaccine sales; 2024 business EPS guidance raised due to strong business performance Sanofi
28-Oct-2024 Inside information: Orion terminates ODM-111 development program due to narrow therapeutic window of the molecule Orion Corporation
28-Oct-2024 Collaborative Breakthrough in Lung-on-Chip Technology Vitrocell
28-Oct-2024 Dupixent late-breaking positive phase 3 data in chronic spontaneous urticaria to be presented at ACAAI Regeneron
28-Oct-2024 iTeos Therapeutics to Highlight Inupadenant Preclinical, Translational, and Phase 2 A2A-005 Clinical Trial Data in 2L NSCLC at ESMO Immuno-Oncology Congress iTeos Therapeutics, Inc
28-Oct-2024 NEW RESEARCH REVEALS LACK OF AWARENESS AROUND ELIGIBILITY FOR WINTER VACCINES Moderna
28-Oct-2024 ONWARD® Medical Successfully Raises EUR 50 Million in an Upsized Capital Increase with Cornerstone Investment from Ottobock SE & Co. KGaA ONWARD Medical N.V.
28-Oct-2024 PolTREG launches Phase 2 cell therapy trial in children with presymptomatic diabetes PolTREG
28-Oct-2024 New imaging technique could spot patients with aggressive brain tumours who would benefit from immunotherapy The Institute of Cancer Research